Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
Crossref DOI link: https://doi.org/10.1186/s12955-016-0541-4
Published Online: 2016-09-30
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kabul, Samaneh
Hood, Robert C.
Duan, Ran
DeLozier, Amy M.
Settles, Julie
Funding for this research was provided by:
Eli Lilly and Company